This webinar is part of a series from the Opioid Response Network (ORN) and American Osteopathic Academy of Addiction Medicine (AOAAM) that takes a closer look at the initiation of buprenorphine in the age of fentanyl, managing opioid complexity in individuals with serious illness and the state of harm reduction in the US.
Dr. Kenneth Stoller, MD, will review a pilot study of pharmacy dispensing of methadone, the use of a secure pillbox for take home doses of methadone, and a survey of OTPs regarding extended take home doses of methadone during the COVID-19 pandemic. He will also review upcoming changes to Federal regulations for OTPs, and discuss how treatment access, quality, safety and patient-centeredness can be maintained and improved.
At the end of the seminar learners will be able to:
- Identify at least two innovative ways to increase access to methadone treatment of opioid use disorder.
- Identify pros and cons to making methadone available through pharmacy prescribing.
- Learners will become familiar with the proposed regulatory changes to 42 CFR Part 8, issued in December 2022.